Am J Psychiatry 157:729-736, May 2000
© 2000 American Psychiatric Association
Comparison of Sertraline and Nortriptyline in the Treatment of Major Depressive Disorder in Late Life
William Bondareff, M.D., Ph.D.,
Murray Alpert, Ph.D.,
Arnold J. Friedhoff, M.D.,
Ellen M. Richter, Ph.D.,
Cathryn M. Clary, M.D., and
Evan Batzar, M.S.
ABSTRACT
OBJECTIVE: This study was designed to evaluate the comparative efficacy and safety of sertraline and nortriptyline for the treatment of major depressive disorder in older adults. METHOD: A double-blind, parallel group design was used to compare 210 outpatients, 60 years of age and older, who met DSM-III-R criteria for major depressive episode and had a minimum Hamilton Depression Rating Scale score of 18. The patients were randomly assigned to 12 weeks of treatment with either sertraline (50–150 mg/day) or nortriptyline (25–100 mg/day). RESULTS: The safety profiles of the two treatments were similar except that nortriptyline treatment was associated with a significant increase in pulse rate, whereas sertraline was associated with a nonsignificant decrease. Efficacy of both drugs was similar for both treatments at all time points, with 71.6% (N=53 of 74) of the sertraline-treated patients and 61.4% (N=43 of 70) of the nortriptyline-treated patients achieving responder status by week 12. Time to response was also similar, with more than 75% of the improvement in scores on the Hamilton depression scale having occurred by week 6. Secondary efficacy measures (posttreatment measures of cognitive function, memory, and quality of life) revealed a significant advantage for sertraline treatment. CONCLUSIONS: Primary efficacy measures showed sertraline and nortriptyline to be similarly effective. With secondary outcome measures there was consistent evidence of an advantage for the sertraline-treated group. The clinical impact of these measures on the long-term well-being of elderly depressed patients should be examined in a study of maintenance treatment.
This article has been cited by other articles:
|
|
|
|
 
J. R. Sneed, B. R. Rutherford, D. Rindskopf, D. T. Lane, H. A. Sackeim, and S. P. Roose
Design Makes a Difference: A Meta-Analysis of Antidepressant Response Rates in Placebo-Controlled Versus Comparator Trials in Late-Life Depression
Am J Geriatr Psychiatry,
January 1, 2008;
16(1):
65 - 73.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Raskin, C. G. Wiltse, A. Siegal, J. Sheikh, J. Xu, J. J. Dinkel, B. T. Rotz, and R. C. Mohs
Efficacy of Duloxetine on Cognition, Depression, and Pain in Elderly Patients With Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled Trial
Am J Psychiatry,
June 1, 2007;
164(6):
900 - 909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Weze, H. L. Leathard, J. Grange, P. Tiplady, and G. Stevens
Healing by Gentle Touch Ameliorates Stress and Other Symptoms in People Suffering with Mental Health Disorders or Psychological Stress
Evid. Based Complement. Altern. Med.,
March 1, 2007;
4(1):
115 - 123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Weintraub, D. Taraborelli, K. H. Morales, J. E. Duda, I. R. Katz, and M. B. Stern
Escitalopram for Major Depression in Parkinson's Disease: An Open-Label, Flexible-Dosage Study
J Neuropsychiatry Clin Neurosci,
August 1, 2006;
18(3):
377 - 383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Nelson, C. M. Clary, A. C. Leon, and L. S. Schneider
Symptoms of Late-Life Depression: Frequency and Change During Treatment
Am J Geriatr Psychiatry,
June 1, 2005;
13(6):
520 - 526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Nelson, M. M. Wohlreich, C. H. Mallinckrodt, M. J. Detke, J. G. Watkin, and J. S. Kennedy
Duloxetine for the Treatment of Major Depressive Disorder in Older Patients
Am J Geriatr Psychiatry,
March 1, 2005;
13(3):
227 - 235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Fochtmann and A. J. Gelenberg
Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition
Focus,
January 1, 2005;
3(1):
34 - 42.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Roose, H. A. Sackeim, K. R. R. Krishnan, B. G. Pollock, G. Alexopoulos, H. Lavretsky, I. R. Katz, H. Hakkarainen, and Old-Old Depression Study Group
Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial
Am J Psychiatry,
November 1, 2004;
161(11):
2050 - 2059.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Ruskin, M. Silver-Aylaian, M. A. Kling, S. A. Reed, D. D. Bradham, J. R. Hebel, D. Barrett, F. Knowles III, and P. Hauser
Treatment Outcomes in Depression: Comparison of Remote Treatment Through Telepsychiatry to In-Person Treatment
Am J Psychiatry,
August 1, 2004;
161(8):
1471 - 1476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Doraiswamy, K. R. R. Krishnan, T. Oxman, L. R. Jenkyn, D. J. Coffey, T. Burt, and C. M. Clary
Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?
J. Gerontol. A Biol. Sci. Med. Sci.,
December 1, 2003;
58(12):
M1137 - 1144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Schneider, J. C. Nelson, C. M. Clary, P. Newhouse, K. R. R. Krishnan, T. Shiovitz, K. Weihs, and the Sertraline Elderly Depression Study Group
An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression
Am J Psychiatry,
July 1, 2003;
160(7):
1277 - 1285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Charney, C. F. Reynolds III, L. Lewis, B. D. Lebowitz, T. Sunderland, G. S. Alexopoulos, D. G. Blazer, I. R. Katz, B. S. Meyers, P. A. Arean, et al.
Depression and Bipolar Support Alliance Consensus Statement on the Unmet Needs in Diagnosis and Treatment of Mood Disorders in Late Life
Arch Gen Psychiatry,
July 1, 2003;
60(7):
664 - 672.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Roose and H. A. Sackeim
Clinical Trials in Late-Life Depression: Revisited
Am J Geriatr Psychiatry,
October 1, 2002;
10(5):
503 - 505.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F. Schatzberg, C. Kremer, H. E. Rodrigues, G. M. Murphy Jr., and The Mirtazapine vs. Paroxetine Study Group
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Am J Geriatr Psychiatry,
October 1, 2002;
10(5):
541 - 550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Doraiswamy, Z. M. Khan, R. M.J. Donahue, and N. E. Richard
The Spectrum of Quality-of-Life Impairments in Recurrent Geriatric Depression
J. Gerontol. A Biol. Sci. Med. Sci.,
February 1, 2002;
57(2):
M134 - 137.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. S. Schneider, G. W. Small, and C. M. Clary
Estrogen Replacement Therapy and Antidepressant Response to Sertraline in Older Depressed Women
Am J Geriatr Psychiatry,
November 1, 2001;
9(4):
393 - 399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. H. Mulsant, B. G. Pollock, R. Nebes, M. D. Miller, R. A. Sweet, J. Stack, P. R. Houck, S. Bensasi, S. Mazumdar, and C. F. Reynolds III
A Twelve-Week, Double-Blind, Randomized Comparison of Nortriptyline and Paroxetine in Older Depressed Inpatients and Outpatients
Am J Geriatr Psychiatry,
November 1, 2001;
9(4):
406 - 414.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Doraiswamy, Z. M. Khan, R. M.J. Donahue, and N. E. Richard
Quality of Life in Geriatric Depression: A Comparison of Remitters, Partial Responders, and Nonresponders
Am J Geriatr Psychiatry,
November 1, 2001;
9(4):
423 - 428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Weintraub
Nortriptyline in Geriatric Depression Resistant to Serotonin Reuptake Inhibitors: Case Series
J Geriatr Psychiatry Neurol,
March 1, 2001;
14(1):
28 - 32.
[Abstract]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
